 |
10 synthetic peptides targeting 5 tumor asociated antigens |
|---|---|
| Trade Name | |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2013-01-23 00:00:00 |
| Sponsor | Orphan Synergy Europe Pharma (OSE Pharma);OSE Pharma Pepiniere Paris Sante Cochin, 29 bis rue du faubourg Saint Jacques;Paris |
Related Access Program